Psychiatry and Neurology, Neurology · Buffalo, NY
NPI
1205848306
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
100 High St
Buffalo, NY, 14203
Phone (716) 859-7051
Groups this clinician bills Medicare through
Medicare paid, 2024
$575K
15,867 services
Medicare patients, 2024
217
Average age 67
Drug cost, 2024
$4.4M
2,286 prescriptions
Company payments, 2025
$54K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David Hojnacki was code J2919 (injection, methylprednisolone sodium succinate, 5 mg), 1,700 times for 15 patients. In total David Hojnacki billed 15,867 services in 36 codes, and Medicare paid $575K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-04-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,700 | 15 | $0.23 | $386 |
| 96415 Chemotherapy Administration | Office | 82 | 19 | $20.14 | $1,651 |
| 70551 MRI/MRA - Head and Neck | Facility | 78 | 76 | $55.32 | $4,315 |
| 96365 Intravenous Infusion, Hydration | Office | 62 | 12 | $48.55 | $3,010 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 60 | 21 | $0.62 | $37.25 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 59 | 51 | $12.09 | $713 |
| 99215 Office E&M - Established | Office | 58 | 47 | $124.99 | $7,249 |
| 96413 Chemotherapy Administration | Office | 32 | 23 | $94.54 | $3,025 |
| 70553 MRI/MRA - Head and Neck | Facility | 31 | 31 | $86.02 | $2,667 |
| 72141 MRI/MRA - Spine | Facility | 25 | 25 | $53.33 | $1,333 |
| 99223 Hospital E&M - Initial | Facility | 22 | 22 | $110.25 | $2,425 |
| 99214 Office E&M - Established | Office | 17 | 15 | $68.49 | $1,164 |
| 72156 MRI/MRA - Spine | Facility | 17 | 17 | $84.95 | $1,444 |
| 99222 Hospital E&M - Initial | Facility | 13 | 13 | $105.43 | $1,371 |
By year: 2022 $406K for 10,065 services; 2023 $451K for 11,978 services; 2024 $575K for 15,867 services.
Medicare prescription drug claims, 2024
In 2024, the drug David Hojnacki prescribed most often to Medicare patients was Baclofen, with 197 prescriptions and refills. In total David Hojnacki wrote 2,286 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 197 | 393 | 54 | $6,423 |
| Gabapentin Generic | 183 | 308 | 38 | $4,937 |
| Avonex Pen (4 Pack) Interferon Beta-1a | 154 | 154 | 15 | $1.3M |
| Dalfampridine Er Dalfampridine | 116 | 116 | 13 | $43K |
| Amitriptyline Hcl Generic | 113 | 245 | 28 | $1,868 |
| Copaxone Glatiramer Acetate | 90 | 92 | 11 | $515K |
| Modafinil Generic | 53 | 61 | Under 11 | $4,583 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 52 | 52 | Under 11 | $167K |
| Tizanidine Hcl Generic | 51 | 115 | 13 | $1,224 |
| Ibuprofen Generic | 49 | 57 | Under 11 | $932 |
| Clonazepam Generic | 47 | 85 | 12 | $765 |
| Glatiramer Acetate Generic | 45 | 45 | Under 11 | $127K |
| Glatopa Glatiramer Acetate | 37 | 42 | Under 11 | $136K |
| Carisoprodol Generic | 36 | 44 | Under 11 | $330 |
| Mycophenolate Mofetil Generic | 34 | 44 | Under 11 | $1,424 |
Brand drugs: 544 claims; generic drugs: 1,742 claims; opioid claims: 38.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David Hojnacki $54K ($54K in general payments such as food, travel and fees) from 14 companies. The largest payer was EMD Serono, Inc. with $38K.
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. MRK.DE | 25 | $38K |
| Biogen, Inc. BIIB | 9 | $15K |
| TG Therapeutics, Inc. TGTX | 2 | $243 |
| Amgen Inc. AMGN | 15 | $199 |
| Pfizer Inc. PFE | 5 | $95.24 |
| Alexion Pharmaceuticals, Inc. AZN | 4 | $87.51 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $81.48 |
| Celgene Corporation BMY | 3 | $53.9 |
| Genentech USA, Inc. ROG.SW | 2 | $51.06 |
| Genzyme Corporation SNY | 1 | $33.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.